Pharmaceutical News and Articles

U.S. Food and Drug Administration Issues Complete Response Letter for the Glepaglutide New Drug Application for the Treatment of Short Bowel Syndrome

FDA Updates Meaning of 'Healthy' on Food Labels

would be considered healthy, as would other nutrient-rich foods like whole grains, dairy, eggs, beans, lentils, seafood, lean meat, nuts and seeds. It s critica

FDA Expands Approval of Vtama to Include Atopic Dermatitis

the topical treatment of atopic dermatitis in adult and pediatric patients aged 2 years and older.The cream, an aryl hydrocarbon receptor agonist, was previousl

Dual-Biomarker Algorithm Can Inform Osteoarthritis Diagnosis

A new diagnostic test using a dual-biomarker algorithm can inform osteoarthritis diagnosis with high accuracy, according to a study published online Dec. 18 in

Cold Weather Deaths Keep Rising for Americans

It s a perhaps unexpected consequence of climate change that periods of deep cold now occur more frequently during American winters, despite an overall trend to

Team Sports, but Not Overall Physical Activity, in Young Childhood Linked to Later Executive Function

Moderate-to-vigorous physical activity (MVPA) in young childhood is not associated with executive function in middle childhood, but participation in team sports

Long-Term Exposure to Air Pollution Tied to More Hospital Admissions

There is an association between long-term exposure to ambient air pollution and increased all-cause and cause-specific hospital admissions for both physical and

Life Expectancy Increased From 2022 to 2023, Reaching 78.4 Years

Life expectancy in the United States increased in 2023, reaching 78.4 years, while drug overdose mortality decreased from 2022 to 2023, according to two Decembe

2013 to 2022 Saw Increase in Influenza Testing at Hospital ED Visits

The use of influenza testing at hospital emergency department visits increased from 2013 to 2022 in the United States, according to a December data brief publis

FDA Says Shortage of GLP-1 Tirzepatide (Mounjaro, Zepbound) Is Over

The U.S. Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes weight-loss medication tirzepatid